{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:56:40Z","timestamp":1791392200971,"version":"4.3.3"},"reference-count":203,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2022,4,30]],"date-time":"2022-04-30T00:00:00Z","timestamp":1651276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Instituto de Salud Carlos IIIISCIII and the European Regional Development Fund (FEDER)","award":["AC18\/00107"],"award-info":[{"award-number":["AC18\/00107"]}]},{"name":"Instituto de Salud Carlos IIIISCIII and the European Regional Development Fund (FEDER)","award":["AC18\/00045"],"award-info":[{"award-number":["AC18\/00045"]}]},{"name":"Instituto de Salud Carlos IIIISCIII and the European Regional Development Fund (FEDER)","award":["PI21\/01262"],"award-info":[{"award-number":["PI21\/01262"]}]},{"name":"Instituto de Salud Carlos IIIISCIII and the European Regional Development Fund (FEDER)","award":["JTC2018-045"],"award-info":[{"award-number":["JTC2018-045"]}]},{"name":"Instituto de Salud Carlos IIIISCIII and the European Regional Development Fund (FEDER)","award":["JTC2018\/ 041"],"award-info":[{"award-number":["JTC2018\/ 041"]}]},{"name":"Instituto de Salud Carlos IIIISCIII and the European Regional Development Fund (FEDER)","award":["IN607B2021\/14"],"award-info":[{"award-number":["IN607B2021\/14"]}]},{"name":"Instituto de Salud Carlos IIIISCIII and the European Regional Development Fund (FEDER)","award":["IN853B 2018\/03"],"award-info":[{"award-number":["IN853B 2018\/03"]}]},{"name":"Instituto de Salud Carlos IIIISCIII and the European Regional Development Fund (FEDER)","award":["ED481A-2018\/095"],"award-info":[{"award-number":["ED481A-2018\/095"]}]},{"name":"Instituto de Salud Carlos IIIISCIII and the European Regional Development Fund (FEDER)","award":["ED431C 2018\/28"],"award-info":[{"award-number":["ED431C 2018\/28"]}]},{"name":"ERA-NET EURONANOMED III project METASTARG","award":["AC18\/00107"],"award-info":[{"award-number":["AC18\/00107"]}]},{"name":"ERA-NET EURONANOMED III project METASTARG","award":["AC18\/00045"],"award-info":[{"award-number":["AC18\/00045"]}]},{"name":"ERA-NET EURONANOMED III project METASTARG","award":["PI21\/01262"],"award-info":[{"award-number":["PI21\/01262"]}]},{"name":"ERA-NET EURONANOMED III project METASTARG","award":["JTC2018-045"],"award-info":[{"award-number":["JTC2018-045"]}]},{"name":"ERA-NET EURONANOMED III project METASTARG","award":["JTC2018\/ 041"],"award-info":[{"award-number":["JTC2018\/ 041"]}]},{"name":"ERA-NET EURONANOMED III project METASTARG","award":["IN607B2021\/14"],"award-info":[{"award-number":["IN607B2021\/14"]}]},{"name":"ERA-NET EURONANOMED III project METASTARG","award":["IN853B 2018\/03"],"award-info":[{"award-number":["IN853B 2018\/03"]}]},{"name":"ERA-NET EURONANOMED III project METASTARG","award":["ED481A-2018\/095"],"award-info":[{"award-number":["ED481A-2018\/095"]}]},{"name":"ERA-NET EURONANOMED III project METASTARG","award":["ED431C 2018\/28"],"award-info":[{"award-number":["ED431C 2018\/28"]}]},{"name":"ERA-NET EURONANOMED III project PANIPAC","award":["AC18\/00107"],"award-info":[{"award-number":["AC18\/00107"]}]},{"name":"ERA-NET EURONANOMED III project PANIPAC","award":["AC18\/00045"],"award-info":[{"award-number":["AC18\/00045"]}]},{"name":"ERA-NET EURONANOMED III project PANIPAC","award":["PI21\/01262"],"award-info":[{"award-number":["PI21\/01262"]}]},{"name":"ERA-NET EURONANOMED III project PANIPAC","award":["JTC2018-045"],"award-info":[{"award-number":["JTC2018-045"]}]},{"name":"ERA-NET EURONANOMED III project PANIPAC","award":["JTC2018\/ 041"],"award-info":[{"award-number":["JTC2018\/ 041"]}]},{"name":"ERA-NET EURONANOMED III project PANIPAC","award":["IN607B2021\/14"],"award-info":[{"award-number":["IN607B2021\/14"]}]},{"name":"ERA-NET EURONANOMED III project PANIPAC","award":["IN853B 2018\/03"],"award-info":[{"award-number":["IN853B 2018\/03"]}]},{"name":"ERA-NET EURONANOMED III project PANIPAC","award":["ED481A-2018\/095"],"award-info":[{"award-number":["ED481A-2018\/095"]}]},{"name":"ERA-NET EURONANOMED III project PANIPAC","award":["ED431C 2018\/28"],"award-info":[{"award-number":["ED431C 2018\/28"]}]},{"name":"Axencia Galega de Innovaci\u00f3n (GAIN), Conseller\u00eda de Econom\u00eda, Emprego e Industria","award":["AC18\/00107"],"award-info":[{"award-number":["AC18\/00107"]}]},{"name":"Axencia Galega de Innovaci\u00f3n (GAIN), Conseller\u00eda de Econom\u00eda, Emprego e Industria","award":["AC18\/00045"],"award-info":[{"award-number":["AC18\/00045"]}]},{"name":"Axencia Galega de Innovaci\u00f3n (GAIN), Conseller\u00eda de Econom\u00eda, Emprego e Industria","award":["PI21\/01262"],"award-info":[{"award-number":["PI21\/01262"]}]},{"name":"Axencia Galega de Innovaci\u00f3n (GAIN), Conseller\u00eda de Econom\u00eda, Emprego e Industria","award":["JTC2018-045"],"award-info":[{"award-number":["JTC2018-045"]}]},{"name":"Axencia Galega de Innovaci\u00f3n (GAIN), Conseller\u00eda de Econom\u00eda, Emprego e Industria","award":["JTC2018\/ 041"],"award-info":[{"award-number":["JTC2018\/ 041"]}]},{"name":"Axencia Galega de Innovaci\u00f3n (GAIN), Conseller\u00eda de Econom\u00eda, Emprego e Industria","award":["IN607B2021\/14"],"award-info":[{"award-number":["IN607B2021\/14"]}]},{"name":"Axencia Galega de Innovaci\u00f3n (GAIN), Conseller\u00eda de Econom\u00eda, Emprego e Industria","award":["IN853B 2018\/03"],"award-info":[{"award-number":["IN853B 2018\/03"]}]},{"name":"Axencia Galega de Innovaci\u00f3n (GAIN), Conseller\u00eda de Econom\u00eda, Emprego e Industria","award":["ED481A-2018\/095"],"award-info":[{"award-number":["ED481A-2018\/095"]}]},{"name":"Axencia Galega de Innovaci\u00f3n (GAIN), Conseller\u00eda de Econom\u00eda, Emprego e Industria","award":["ED431C 2018\/28"],"award-info":[{"award-number":["ED431C 2018\/28"]}]},{"name":"Roche-Chus Joint Unit, Axencia Galega de Innovaci\u00f3n (GAIN), Conseller\u00eda de Econom\u00eda, Emprego e Industria","award":["AC18\/00107"],"award-info":[{"award-number":["AC18\/00107"]}]},{"name":"Roche-Chus Joint Unit, Axencia Galega de Innovaci\u00f3n (GAIN), Conseller\u00eda de Econom\u00eda, Emprego e Industria","award":["AC18\/00045"],"award-info":[{"award-number":["AC18\/00045"]}]},{"name":"Roche-Chus Joint Unit, Axencia Galega de Innovaci\u00f3n (GAIN), Conseller\u00eda de Econom\u00eda, Emprego e Industria","award":["PI21\/01262"],"award-info":[{"award-number":["PI21\/01262"]}]},{"name":"Roche-Chus Joint Unit, Axencia Galega de Innovaci\u00f3n (GAIN), Conseller\u00eda de Econom\u00eda, Emprego e Industria","award":["JTC2018-045"],"award-info":[{"award-number":["JTC2018-045"]}]},{"name":"Roche-Chus Joint Unit, Axencia Galega de Innovaci\u00f3n (GAIN), Conseller\u00eda de Econom\u00eda, Emprego e Industria","award":["JTC2018\/ 041"],"award-info":[{"award-number":["JTC2018\/ 041"]}]},{"name":"Roche-Chus Joint Unit, Axencia Galega de Innovaci\u00f3n (GAIN), Conseller\u00eda de Econom\u00eda, Emprego e Industria","award":["IN607B2021\/14"],"award-info":[{"award-number":["IN607B2021\/14"]}]},{"name":"Roche-Chus Joint Unit, Axencia Galega de Innovaci\u00f3n (GAIN), Conseller\u00eda de Econom\u00eda, Emprego e Industria","award":["IN853B 2018\/03"],"award-info":[{"award-number":["IN853B 2018\/03"]}]},{"name":"Roche-Chus Joint Unit, Axencia Galega de Innovaci\u00f3n (GAIN), Conseller\u00eda de Econom\u00eda, Emprego e Industria","award":["ED481A-2018\/095"],"award-info":[{"award-number":["ED481A-2018\/095"]}]},{"name":"Roche-Chus Joint Unit, Axencia Galega de Innovaci\u00f3n (GAIN), Conseller\u00eda de Econom\u00eda, Emprego e Industria","award":["ED431C 2018\/28"],"award-info":[{"award-number":["ED431C 2018\/28"]}]},{"name":"Xunta de Galicia Pre-doctoral Fellowship","award":["AC18\/00107"],"award-info":[{"award-number":["AC18\/00107"]}]},{"name":"Xunta de Galicia Pre-doctoral Fellowship","award":["AC18\/00045"],"award-info":[{"award-number":["AC18\/00045"]}]},{"name":"Xunta de Galicia Pre-doctoral Fellowship","award":["PI21\/01262"],"award-info":[{"award-number":["PI21\/01262"]}]},{"name":"Xunta de Galicia Pre-doctoral Fellowship","award":["JTC2018-045"],"award-info":[{"award-number":["JTC2018-045"]}]},{"name":"Xunta de Galicia Pre-doctoral Fellowship","award":["JTC2018\/ 041"],"award-info":[{"award-number":["JTC2018\/ 041"]}]},{"name":"Xunta de Galicia Pre-doctoral Fellowship","award":["IN607B2021\/14"],"award-info":[{"award-number":["IN607B2021\/14"]}]},{"name":"Xunta de Galicia Pre-doctoral Fellowship","award":["IN853B 2018\/03"],"award-info":[{"award-number":["IN853B 2018\/03"]}]},{"name":"Xunta de Galicia Pre-doctoral Fellowship","award":["ED481A-2018\/095"],"award-info":[{"award-number":["ED481A-2018\/095"]}]},{"name":"Xunta de Galicia Pre-doctoral Fellowship","award":["ED431C 2018\/28"],"award-info":[{"award-number":["ED431C 2018\/28"]}]},{"name":"Conseller\u00eda de Educaci\u00f3n, Universidade e Formaci\u00f3n Profesional, Xunta de Galicia local government","award":["AC18\/00107"],"award-info":[{"award-number":["AC18\/00107"]}]},{"name":"Conseller\u00eda de Educaci\u00f3n, Universidade e Formaci\u00f3n Profesional, Xunta de Galicia local government","award":["AC18\/00045"],"award-info":[{"award-number":["AC18\/00045"]}]},{"name":"Conseller\u00eda de Educaci\u00f3n, Universidade e Formaci\u00f3n Profesional, Xunta de Galicia local government","award":["PI21\/01262"],"award-info":[{"award-number":["PI21\/01262"]}]},{"name":"Conseller\u00eda de Educaci\u00f3n, Universidade e Formaci\u00f3n Profesional, Xunta de Galicia local government","award":["JTC2018-045"],"award-info":[{"award-number":["JTC2018-045"]}]},{"name":"Conseller\u00eda de Educaci\u00f3n, Universidade e Formaci\u00f3n Profesional, Xunta de Galicia local government","award":["JTC2018\/ 041"],"award-info":[{"award-number":["JTC2018\/ 041"]}]},{"name":"Conseller\u00eda de Educaci\u00f3n, Universidade e Formaci\u00f3n Profesional, Xunta de Galicia local government","award":["IN607B2021\/14"],"award-info":[{"award-number":["IN607B2021\/14"]}]},{"name":"Conseller\u00eda de Educaci\u00f3n, Universidade e Formaci\u00f3n Profesional, Xunta de Galicia local government","award":["IN853B 2018\/03"],"award-info":[{"award-number":["IN853B 2018\/03"]}]},{"name":"Conseller\u00eda de Educaci\u00f3n, Universidade e Formaci\u00f3n Profesional, Xunta de Galicia local government","award":["ED481A-2018\/095"],"award-info":[{"award-number":["ED481A-2018\/095"]}]},{"name":"Conseller\u00eda de Educaci\u00f3n, Universidade e Formaci\u00f3n Profesional, Xunta de Galicia local government","award":["ED431C 2018\/28"],"award-info":[{"award-number":["ED431C 2018\/28"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Cancer causes millions of deaths each year and thus urgently requires the development of new therapeutic strategies. Nanotechnology-based anticancer therapies are a promising approach, with several formulations already approved and in clinical use. The evaluation of these therapies requires efficient in vivo models to study their behavior and interaction with cancer cells, and to optimize their properties to ensure maximum efficacy and safety. In this way, zebrafish is an important candidate due to its high homology with the human genoma, its large offspring, and the ease in developing specific cancer models. The role of zebrafish as a model for anticancer therapy studies has been highly evidenced, allowing researchers not only to perform drug screenings but also to evaluate novel therapies such as immunotherapies and nanotherapies. Beyond that, zebrafish can be used as an \u201cavatar\u201d model for performing patient-derived xenografts for personalized medicine. These characteristics place zebrafish in an attractive position as a role model for evaluating novel therapies for cancer treatment, such as nanomedicine.<\/jats:p>","DOI":"10.3390\/cancers14092238","type":"journal-article","created":{"date-parts":[[2022,4,30]],"date-time":"2022-04-30T05:44:07Z","timestamp":1651297447000},"page":"2238","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["What Zebrafish and Nanotechnology Can Offer for Cancer Treatments in the Age of Personalized Medicine"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4256-9695","authenticated-orcid":false,"given":"Mar\u00eda","family":"Cascallar","sequence":"first","affiliation":[{"name":"Nano-Oncology and Translational Therapeutics Group, Health Research Institute of Santiago de Compostela (IDIS), SERGAS, 15706 Santiago de Compostela, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red C\u00e1ncer (CIBERONC), 28029 Madrid, Spain"},{"name":"Department of Zoology, Genetics and Physical Anthropology, Universidade de Santiago de Compostela, Campus de Lugo, 27002 Lugo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Alijas","sequence":"additional","affiliation":[{"name":"Nano-Oncology and Translational Therapeutics Group, Health Research Institute of Santiago de Compostela (IDIS), SERGAS, 15706 Santiago de Compostela, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1622-3068","authenticated-orcid":false,"given":"Alba","family":"Pensado-L\u00f3pez","sequence":"additional","affiliation":[{"name":"Department of Zoology, Genetics and Physical Anthropology, Universidade de Santiago de Compostela, Campus de Lugo, 27002 Lugo, Spain"},{"name":"Center for Research in Molecular Medicine & Chronic Diseases (CIMUS), Campus Vida, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5345-3682","authenticated-orcid":false,"given":"Abi","family":"V\u00e1zquez-R\u00edos","sequence":"additional","affiliation":[{"name":"Nano-Oncology and Translational Therapeutics Group, Health Research Institute of Santiago de Compostela (IDIS), SERGAS, 15706 Santiago de Compostela, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red C\u00e1ncer (CIBERONC), 28029 Madrid, Spain"},{"name":"DIVERSA Technologies S.L., 15782 Santiago de Compostela, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7927-5303","authenticated-orcid":false,"given":"Laura","family":"S\u00e1nchez","sequence":"additional","affiliation":[{"name":"Department of Zoology, Genetics and Physical Anthropology, Universidade de Santiago de Compostela, Campus de Lugo, 27002 Lugo, Spain"},{"name":"Preclinical Animal Models Group, Health Research Institute of Santiago de Compostela (IDIS), 15706 Santiago de Compostela, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9479-139X","authenticated-orcid":false,"given":"Roberto","family":"Pi\u00f1eiro","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red C\u00e1ncer (CIBERONC), 28029 Madrid, Spain"},{"name":"Roche-Chus Joint Unit, Translational Medical Oncology Group, Oncomet, Health Research Institute of Santiago de Compostela, Traves\u00eda da Choupana s\/n, 15706 Santiago de Compostela, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"de la Fuente","sequence":"additional","affiliation":[{"name":"Nano-Oncology and Translational Therapeutics Group, Health Research Institute of Santiago de Compostela (IDIS), SERGAS, 15706 Santiago de Compostela, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red C\u00e1ncer (CIBERONC), 28029 Madrid, Spain"},{"name":"DIVERSA Technologies S.L., 15782 Santiago de Compostela, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,4,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21590","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.1002\/cam4.2474","article-title":"Are 90% of deaths from cancer caused by metastases?","volume":"8","author":"Rogers","year":"2019","journal-title":"Cancer Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"9694","DOI":"10.3748\/wjg.v22.i44.9694","article-title":"Epidemiology of pancreatic cancer","volume":"22","author":"Ilic","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJMoa1916623","article-title":"The Effect of Advances in Lung-Cancer Treatment on Population Mortality","volume":"383","author":"Howlader","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"San Juan, B.P., Garcia-Leon, M.J., Rangel, L., Goetz, J.G., and Chaffer, C.L. (2019). The complexities of metastasis. Cancers, 11.","DOI":"10.3390\/cancers11101575"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ccr.2007.12.003","article-title":"Systemic Spread Is an Early Step in Breast Cancer","volume":"13","author":"Geigl","year":"2008","journal-title":"Cancer Cell"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3109\/09553002.2014.886798","article-title":"Cancer stem cell characteristics of circulating tumor cells","volume":"90","author":"Tinhofer","year":"2014","journal-title":"Int. J. Radiat. Biol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.trecan.2017.04.009","article-title":"Metabolism during ECM Detachment: Achilles Heel of Cancer Cells?","volume":"3","author":"Mason","year":"2017","journal-title":"Trends Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1042\/BCJ20170164","article-title":"Cancer stem cells (CSCs): Metabolic strategies for their identification and eradication","volume":"475","author":"Sotgia","year":"2018","journal-title":"Biochem. J."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Santamar\u00eda, P.G., Moreno-Bueno, G., and Cano, A. (2019). Contribution of Epithelial Plasticity to Therapy Resistance. J. Clin. Med., 8.","DOI":"10.3390\/jcm8050676"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/s41419-019-1898-1","article-title":"Lung tumorspheres reveal cancer stem cell-like properties and a score with prognostic impact in resected non-small-cell lung cancer","volume":"10","author":"Lucas","year":"2019","journal-title":"Cell Death Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1056\/NEJMoa011954","article-title":"Comparison of Four Chemotherapy Regimens for Advanced Non\u2013Small-Cell Lung Cancer","volume":"346","author":"Schiller","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3389\/fmed.2017.00004","article-title":"Historical evolution of second-line therapy in non-small cell lung cancer","volume":"4","author":"Lazzari","year":"2017","journal-title":"Front. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41392-019-0099-9","article-title":"The emerging treatment landscape of targeted therapy in non-small-cell lung cancer","volume":"4","author":"Yuan","year":"2019","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_17","unstructured":"Committee for Medicinal Products for Human Use (CHMP) (2006). Annex I Summary of Product Characteristics."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1158\/1535-7163.MCT-15-0879","article-title":"A phase I trial to evaluate antibody-dependent cellular cytotoxicity of cetuximab and lenalidomide in advanced colorectal and head and neck cancer","volume":"15","author":"Bertino","year":"2016","journal-title":"Mol. Cancer Ther."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e120858","DOI":"10.1172\/jci.insight.120858","article-title":"Personalized therapy for lung cancer: Striking a moving target","volume":"3","author":"Pakkala","year":"2018","journal-title":"JCI Insight"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved Survival with Ipilimumab in Patients with Metastatic Melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1056\/NEJMoa1412082","article-title":"Nivolumab in Previously Untreated Melanoma without BRAF Mutation","volume":"372","author":"Robert","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJMoa1507643","article-title":"Nivolumab versus Docetaxel in Advanced Nonsquamous Non\u2013Small-Cell Lung Cancer","volume":"373","author":"Borghaei","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa1504627","article-title":"Nivolumab versus Docetaxel in Advanced Squamous-Cell Non\u2013Small-Cell Lung Cancer","volume":"373","author":"Brahmer","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1056\/NEJMoa1510665","article-title":"Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma","volume":"373","author":"Motzer","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1080\/21645515.2020.1723363","article-title":"Recent advances of oncolytic virus in cancer therapy","volume":"16","author":"Mondal","year":"2020","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1158\/2159-8290.CD-18-0367","article-title":"Fundamental Mechanisms of Immune Checkpoint Blockade Therapy","volume":"8","author":"Wei","year":"2018","journal-title":"Cancer Discov."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.imlet.2018.01.011","article-title":"Therapeutic cancer vaccines: From initial findings to prospects","volume":"196","author":"Song","year":"2018","journal-title":"Immunol. Lett."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"118186","DOI":"10.1016\/j.lfs.2020.118186","article-title":"Antioxidants with two faces toward cancer","volume":"258","author":"Dastmalchi","year":"2020","journal-title":"Life Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s12253-018-00569-x","article-title":"Hormone Replacement Therapy in Cancer Survivors\u2013Review of the Literature","volume":"26","author":"Deli","year":"2020","journal-title":"Pathol. Oncol. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"9355","DOI":"10.2147\/IJN.S281890","article-title":"Advances in Exosome-Based Drug Delivery and Tumor Targeting: From Tissue Distribution to Intracellular Fate","volume":"15","author":"Shao","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Fu, Z., and Xiang, J. (2020). Aptamers, the Nucleic Acid Antibodies, in Cancer Therapy. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21082793"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Vilas-Boas, V., Carvalho, F., and Espi\u00f1a, B. (2020). Magnetic Hyperthermia for Cancer Treatment: Main Parameters Affecting the Outcome of In Vitro and In Vivo Studies. Molecules, 25.","DOI":"10.3390\/molecules25122874"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"4436","DOI":"10.1158\/1078-0432.CCR-14-0012","article-title":"FDA approval: Ado-trastuzumab emtansine for the treatment of patients with HER2-positive metastatic breast cancer","volume":"20","author":"Blumenthal","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1001\/jama.2017.15218","article-title":"FDA Approval of Tisagenlecleucel Promise and Complexities of a $475 000 Cancer Drug","volume":"318","year":"2017","journal-title":"JAMA"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil\u00ae\u2014The first FDA-approved nano-drug: Lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J. Control. Release"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"V\u00e1zquez-R\u00edos, A.J., Alonso-Nocelo, M., L\u00f3pez Bouzo, B., Ruiz-Ba\u00f1obre, J., and de la Fuente, M. (2018). Nanotheranostics and their potential in the management of metastatic cancer. Handbook of Nanomaterials for Cancer Theranostics, Elsevier.","DOI":"10.1016\/B978-0-12-813339-2.00008-6"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nnano.2007.387","article-title":"Nanocarriers as an emerging platform for cancer therapy","volume":"2","author":"Peer","year":"2007","journal-title":"Nat. Nanotechnol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/aps.2018.33","article-title":"Importance of integrating nanotechnology with pharmacology and physiology for innovative drug delivery and therapy-An illustration with firsthand examples","volume":"39","author":"Zhang","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_39","first-page":"467","article-title":"Targeted therapy using nanotechnology: Focus on cancer","volume":"9","author":"Sanna","year":"2014","journal-title":"Int. J. Nanomed."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2217\/nnm-2018-0120","article-title":"Nanopharmaceuticals and nanomedicines currently on the market: Challenges and opportunities","volume":"14","author":"Farjadian","year":"2019","journal-title":"Nanomedicine"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"120438","DOI":"10.1016\/j.ijpharm.2021.120438","article-title":"Advanced nanomedicine and cancer: Challenges and opportunities in clinical translation","volume":"599","author":"Girotti","year":"2021","journal-title":"Int. J. Pharm."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1038\/s41563-021-01047-7","article-title":"Obstacles and opportunities in a forward vision for cancer nanomedicine","volume":"20","author":"Mooney","year":"2021","journal-title":"Nat. Mater."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e10143","DOI":"10.1002\/btm2.10143","article-title":"Nanoparticles in the clinic: An update","volume":"4","author":"Anselmo","year":"2019","journal-title":"Bioeng. Transl. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jconrel.2021.12.030","article-title":"Evolution of drug delivery systems: From 1950 to 2020 and beyond","volume":"342","author":"Park","year":"2022","journal-title":"J. Control. Release"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1089\/adt.2010.0346","article-title":"The Zebrafish: A powerful platform for in vivo, HTS drug discovery","volume":"9","author":"Delvecchio","year":"2011","journal-title":"Assay Drug Dev. Technol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nrg2091","article-title":"Animal models of human disease: Zebrafish swim into view","volume":"8","author":"Lieschke","year":"2007","journal-title":"Nat. Rev. Genet."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1101\/gr.9.2.99","article-title":"Zebrafish: A new model for human disease","volume":"9","author":"Zon","year":"1999","journal-title":"Genome Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/nature12111","article-title":"The zebrafish reference genome sequence and its relationship to the human genome","volume":"496","author":"Howe","year":"2013","journal-title":"Nature"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.addr.2019.01.001","article-title":"Zebrafish as a preclinical in vivo screening model for nanomedicines","volume":"151\u2013152","author":"Sieber","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13046-015-0196-8","article-title":"A fresh look at zebrafish from the perspective of cancer research","volume":"34","author":"Zhao","year":"2015","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0145-305X(03)00103-4","article-title":"Development and maturation of the immune system in zebrafish, Danio rerio: A gene expression profiling, in situ hybridization and immunological study","volume":"28","author":"Lam","year":"2004","journal-title":"Dev. Comp. Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/zeb.2010.9996","article-title":"The new age of chemical screening in Zebrafish","volume":"7","author":"Zon","year":"2010","journal-title":"Zebrafish"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Raby, L., V\u00f6lkel, P., Le Bourhis, X., and Angrand, P.O. (2020). Genetic engineering of zebrafish in cancer research. Cancers, 12.","DOI":"10.3390\/cancers12082168"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1177\/019262330002800512","article-title":"Neoplasia in zebrafish (Danio rerio) treated with N-methyl-N\u2019-nitro-N-nitrosoguanidine by three exposure routes at different developmental stages","volume":"28","author":"Spitsbergen","year":"2000","journal-title":"Toxicol. Pathol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1177\/019262330002800511","article-title":"Neoplasia in zebrafish (Danio rerio) treated with 7,12-dimethylbenz[a]anthracene by two exposure routes at different developmental stages","volume":"28","author":"Spitsbergen","year":"2000","journal-title":"Toxicol. Pathol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nbt1169","article-title":"Conservation of gene expression signatures between zebrafish and human liver tumors and tumor progression","volume":"24","author":"Siew","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Fujisawa, K., Terai, S., Matsumoto, T., Takami, T., Yamamoto, N., Nishina, H., Furutani-Seiki, M., and Sakaida, I. (2015). Evidence for a role of the transcriptional regulator Maid in tumorigenesis and aging. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0137156"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0166-445X(98)00121-0","article-title":"Tumor suppression in triploid trout","volume":"46","author":"Thorgaard","year":"1999","journal-title":"Aquat. Toxicol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1080\/01926230490496311","article-title":"Carcinogenic Effect of N-Nitrosodimethylamine on Diploid and Triploid Zebrafish (Danio rerio)","volume":"32","author":"Mizgireuv","year":"2016","journal-title":"Toxicol. Pathol."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Basten, S.G., Davis, E.E., Gillis, A.J.M., van Rooijen, E., Stoop, H., Babala, N., Logister, I., Heath, Z.G., Jonges, T.N., and Katsanis, N. (2013). Mutations in LRRC50 Predispose Zebrafish and Humans to Seminomas. PLoS Genet., 9.","DOI":"10.1371\/journal.pgen.1003384"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1089\/zeb.2009.0613","article-title":"Identification of a heritable model of testicular germ cell tumor in the zebrafish","volume":"6","author":"Neumann","year":"2009","journal-title":"Zebrafish"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.1182\/blood-2006-05-024075","article-title":"A transgenic zebrafish model of neutrophilic inflammation","volume":"108","author":"Renshaw","year":"2006","journal-title":"Blood"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1182\/blood-2010-10-314120","article-title":"mpeg1 promoter transgenes direct macrophage-lineage expression in zebrafish","volume":"117","author":"Ellett","year":"2011","journal-title":"Blood"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1006\/dbio.2002.0711","article-title":"In vivo imaging of embryonic vascular development using transgenic zebrafish","volume":"248","author":"Lawson","year":"2002","journal-title":"Dev. Biol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1053\/j.gastro.2008.02.084","article-title":"Oncogenic KRAS Induces Progenitor Cell Expansion and Malignant Transformation in Zebrafish Exocrine Pancreas","volume":"134","author":"Park","year":"2008","journal-title":"Gastroenterology"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1242\/dmm.001149","article-title":"Dissecting the roles of Raf- and PI3K-signalling pathways in melanoma formation and progression in a zebrafish model","volume":"2","author":"Michailidou","year":"2009","journal-title":"DMM Dis. Model. Mech."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.cub.2005.01.031","article-title":"BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma","volume":"15","author":"Patton","year":"2005","journal-title":"Curr. Biol."},{"key":"ref_68","first-page":"161","article-title":"GAL4\/UAS Targeted Gene Expression for Studying Drosophila Hedgehog Signaling","volume":"Volume 397","author":"Busson","year":"2007","journal-title":"Hedgehog Signaling Protocols"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1038\/leu.2013.132","article-title":"Targeting oncogene expression to endothelial cells induces proliferation of the myelo-erythroid lineage by repressing the notch pathway","volume":"27","author":"Alghisi","year":"2013","journal-title":"Leukemia"},{"key":"ref_70","first-page":"15","article-title":"A novel brain tumour model in zebrafish reveals the role of YAP activation in MAPK- and PI3K-induced malignant growth","volume":"10","author":"Mayrhofer","year":"2017","journal-title":"DMM Dis. Model. Mech."},{"key":"ref_71","first-page":"907","article-title":"A zebrafish model of chordoma initiated by notochord-driven expression of HRASV12","volume":"7","author":"Burger","year":"2014","journal-title":"DMM Dis. Model. Mech."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12943-015-0288-2","article-title":"Oncogenic KRAS promotes malignant brain tumors in zebrafish","volume":"14","author":"Ju","year":"2015","journal-title":"Mol. Cancer"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/79951","article-title":"Effective targeted gene \u201cknockdown\u201d in zebrafish","volume":"26","author":"Nasevicius","year":"2000","journal-title":"Nat. Genet."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"57851","DOI":"10.18632\/oncotarget.11072","article-title":"Inhibition of PlexA1-mediated brain tumor growth and tumor-associated angiogenesis using a transmembrane domain targeting peptide","volume":"7","author":"Jacob","year":"2016","journal-title":"Oncotarget"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"23750","DOI":"10.18632\/oncotarget.16077","article-title":"Ephrin-B3 supports glioblastoma growth by inhibiting apoptosis induced by the dependence receptor EphA4","volume":"8","author":"Royet","year":"2017","journal-title":"Oncotarget"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1101\/gr.1725103","article-title":"Efficient target-selected mutagenesis in zebrafish","volume":"13","author":"Wienholds","year":"2003","journal-title":"Genome Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1073\/pnas.0406252102","article-title":"tp53 mutant zebrafish develop malignant peripheral nerve sheath tumors","volume":"102","author":"Berghmans","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/sj.onc.1210730","article-title":"Zebrafish pten genes have overlapping and non-redundant functions in tumorigenesis and embryonic development","volume":"27","author":"Faucherre","year":"2008","journal-title":"Oncogene"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1242\/dmm.008326","article-title":"Haploinsufficiency of the genes encoding the tumor suppressor Pten predisposes zebrafish to hemangiosarcoma","volume":"5","author":"Choorapoikayil","year":"2012","journal-title":"DMM Dis. Model. Mech."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/sj.embor.7400638","article-title":"Adenomatous polyposis coli-deficient zebrafish are susceptible to digestive tract neoplasia","volume":"7","author":"Haramis","year":"2006","journal-title":"EMBO Rep."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"19350","DOI":"10.1073\/pnas.1011630107","article-title":"Brca2 in zebrafish ovarian development, spermatogenesis, and tumorigenesis","volume":"107","author":"Shive","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.1158\/0008-5472.CAN-11-3148","article-title":"A zebrafish model to study and therapeutically manipulate hypoxia signaling in tumorigenesis","volume":"72","author":"Santhakumar","year":"2012","journal-title":"Cancer Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1128\/MCB.00971-14","article-title":"A Zebrafish Model of Myelodysplastic Syndrome Produced through tet2 Genomic Editing","volume":"35","author":"Gjini","year":"2015","journal-title":"Mol. Cell. Biol."},{"key":"ref_84","first-page":"881","article-title":"Zebrafish neurofibromatosis type 1 genes have redundant functions in tumorigenesis and embryonic development","volume":"5","author":"Shin","year":"2012","journal-title":"DMM Dis. Model. Mech."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"55280","DOI":"10.18632\/oncotarget.19424","article-title":"Development of zebrafish medulloblastoma-like PNET model by TALEN-mediated somatic gene inactivation","volume":"8","author":"Shim","year":"2017","journal-title":"Oncotarget"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Oppel, F., Tao, T., Shi, H., Ross, K.N., Zimmerman, M.W., He, S., Tong, G., Aster, J.C., and Thomas Look, A. (2019). Loss of atrx cooperates with p53-deficiency to promote the development of sarcomas and other malignancies. PLoS Genet., 15.","DOI":"10.1371\/journal.pgen.1008039"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"dmm042341","DOI":"10.1242\/dmm.042341","article-title":"suz12 inactivation in p53- And nf1-deficient zebrafish accelerates the onset of malignant peripheral nerve sheath tumors and expands the spectrum of tumor types","volume":"13","author":"Oppel","year":"2020","journal-title":"DMM Dis. Model. Mech."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/978-3-319-30654-4_12","article-title":"Allograft cancer cell transplantation in zebrafish","volume":"Volume 916","author":"Moore","year":"2016","journal-title":"Advances in Experimental Medicine and Biology"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1038\/nprot.2007.412","article-title":"The zebrafish\/tumor xenograft angiogenesis assay","volume":"2","author":"Nicoli","year":"2007","journal-title":"Nat. Protoc."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1242\/dmm.015784","article-title":"Hooking the big one: The potential of zebrafish xenotransplantation to reform cancer drug screening in the genomic era","volume":"7","author":"Veinotte","year":"2014","journal-title":"DMM Dis. Model. Mech."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Mercatali, L., La Manna, F., Groenewoud, A., Casadei, R., Recine, F., Miserocchi, G., Pieri, F., Liverani, C., Bongiovanni, A., and Spadazzi, C. (2016). Development of a patient-derived xenograft (PDX) of breast cancer bone metastasis in a Zebrafish model. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17081375"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bcmd.2018.12.007","article-title":"An efficient method to generate xenograft tumor models of acute myeloid leukemia and hepatocellular carcinoma in adult zebrafish","volume":"75","author":"Khan","year":"2019","journal-title":"Blood Cells, Mol. Dis."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1186\/s13046-019-1389-3","article-title":"Zebrafish modeling reveals that SPINT1 regulates the aggressiveness of skin cutaneous melanoma and its crosstalk with tumor immune microenvironment","volume":"38","author":"Fuentes","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/nmeth.3031","article-title":"Optimized cell transplantation using adult rag2 mutant zebrafsh","volume":"11","author":"Tang","year":"2014","journal-title":"Nat. Methods"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/j.cell.2019.04.004","article-title":"Visualizing Engrafted Human Cancer and Therapy Responses in Immunodeficient Zebrafish","volume":"177","author":"Yan","year":"2019","journal-title":"Cell"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"6048","DOI":"10.1158\/0008-5472.CAN-18-1029","article-title":"Zebrafish: Speeding up the cancer drug discovery process","volume":"78","author":"Letrado","year":"2018","journal-title":"Cancer Res."},{"key":"ref_97","first-page":"e2790","article-title":"Quantifying the frequency of tumor-propagating cells using limiting dilution cell transplantation in syngeneic zebrafish","volume":"14","author":"Blackburn","year":"2011","journal-title":"J. Vis. Exp."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1182\/blood-2009-10-246488","article-title":"High-throughput cell transplantation establishes that tumor-initiating cells are abundant in zebrafish T-cell acute lymphoblastic leukemia","volume":"115","author":"Smith","year":"2010","journal-title":"Blood"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ccr.2014.01.032","article-title":"Clonal evolution enhances leukemia-propagating cell frequency in T cell acute lymphoblastic leukemia through Akt\/mTORC1 pathway activation","volume":"25","author":"Blackburn","year":"2014","journal-title":"Cancer Cell"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"e37202","DOI":"10.7554\/eLife.37202","article-title":"Tp53 deficiency causes a wide tumor spectrum and increases embryonal rhabdomyosarcoma metastasis in zebrafish","volume":"7","author":"Ignatius","year":"2018","journal-title":"eLife"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.stem.2007.11.002","article-title":"Transparent Adult Zebrafish as a Tool for In Vivo Transplantation Analysis","volume":"2","author":"White","year":"2008","journal-title":"Cell Stem Cell"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/dvdy.20471","article-title":"The fate of human malignant melanoma cells transplanted into zebrafish embryos: Assessment of migration and cell division in the absence of tumor formation","volume":"233","author":"Lee","year":"2005","journal-title":"Dev. Dyn."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Cabezas-S\u00e1inz, P., Pensado-L\u00f3pez, A., S\u00e1inz, B., and S\u00e1nchez, L. (2020). Modeling Cancer Using Zebrafish Xenografts: Drawbacks for Mimicking the Human Microenvironment. Cells, 9.","DOI":"10.3390\/cells9091978"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/path.4013","article-title":"Neutrophil-mediated experimental metastasis is enhanced by VEGFR inhibition in a zebrafish xenograft model","volume":"227","author":"He","year":"2012","journal-title":"J. Pathol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.devcel.2017.11.003","article-title":"Macrophage-Dependent Cytoplasmic Transfer during Melanoma Invasion In Vivo","volume":"43","author":"Shah","year":"2017","journal-title":"Dev. Cell"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.12688\/f1000research.16659.2","article-title":"Embryonic zebrafish xenograft assay of human cancer metastasis","volume":"7","author":"Hill","year":"2018","journal-title":"F1000Research"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"dmm035998","DOI":"10.1242\/dmm.035998","article-title":"Macrophages enhance Vegfa-driven angiogenesis in an embryonic zebrafish tumour xenograft model","volume":"11","author":"Britto","year":"2018","journal-title":"DMM Dis. Model. Mech."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"jcs231563","DOI":"10.1242\/jcs.231563","article-title":"Circulating tumor cells exit circulation while maintaining multicellularity, augmenting metastatic potential","volume":"132","author":"Allen","year":"2019","journal-title":"J. Cell Sci."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/jnr.22794","article-title":"Calpain 2 is required for the invasion of glioblastoma cells in the zebrafish brain microenvironment","volume":"90","author":"Lal","year":"2012","journal-title":"J. Neurosci. Res."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.bbrc.2018.10.076","article-title":"Quantification of glioblastoma progression in zebrafish xenografts: Adhesion to laminin alpha 5 promotes glioblastoma microtumor formation and inhibits cell invasion","volume":"506","author":"Gamble","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"14372","DOI":"10.1038\/s41598-017-14766-2","article-title":"Identify a Blood-Brain Barrier Penetrating Drug-TNB using Zebrafish Orthotopic Glioblastoma Xenograft Model","volume":"7","author":"Zeng","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s40478-019-0785-4","article-title":"Downregulation of Nodal inhibits metastatic progression in retinoblastoma","volume":"7","author":"Asnaghi","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Marques, I.J., Weiss, F.U., Vlecken, D.H., Nitsche, C., Bakkers, J., Lagendijk, A.K., Partecke, L.I., Heidecke, C.D., Lerch, M.M., and Bagowski, C.P. (2009). Metastatic behaviour of primary human tumours in a zebrafish xenotransplantation model. BMC Cancer, 9.","DOI":"10.1186\/1471-2407-9-128"},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Usai, A., Di Franco, G., Colucci, P., Pollina, L.E., Vasile, E., Funel, N., Palmeri, M., Dente, L., Falcone, A., and Morelli, L. (2020). A model of a zebrafish avatar for co-clinical trials. Cancers, 12.","DOI":"10.3390\/cancers12030677"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s12967-019-1985-1","article-title":"PCR-based zebrafish model for personalised medicine in head and neck cancer","volume":"17","author":"Tuomainen","year":"2019","journal-title":"J. Transl. Med."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1002\/ijc.30613","article-title":"Dopamine receptor type 2 (DRD2) and somatostatin receptor type 2 (SSTR2) agonists are effective in inhibiting proliferation of progenitor\/stem-like cells isolated from nonfunctioning pituitary tumors","volume":"140","author":"Peverelli","year":"2017","journal-title":"Int. J. Cancer"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1242\/bio.023911","article-title":"Innovative approaches to establish and characterize primary cultures: An ex vivo 3D system and the zebrafish model","volume":"6","author":"Liverani","year":"2017","journal-title":"Biol. Open"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3324\/haematol.2014.110742","article-title":"Focused chemical genomics using zebrafish xenotransplantation as a pre-clinical therapeutic platform for T-cell acute lymphoblastic leukemia","volume":"100","author":"Bentley","year":"2015","journal-title":"Haematologica"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"12965","DOI":"10.1073\/pnas.97.24.12965","article-title":"Small molecule developmental screens reveal the logic and timing of vertebrate development","volume":"97","author":"Peterson","year":"2020","journal-title":"Natl. Acad Sci."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1210\/en.2019-00152","article-title":"Adrenocortical Carcinoma Xenograft in Zebrafish Embryos as a Model To Study the In Vivo Cytotoxicity of Abiraterone Acetate","volume":"160","author":"Gianoncelli","year":"2019","journal-title":"Endocrinology"},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Cabezas-Sainz, P., Guerra-Varela, J., Carreira, M.J., Mariscal, J., Roel, M., Rubiolo, J.A., Sciara, A.A., Abal, M., Botana, L.M., and L\u00f3pez, R. (2018). Improving zebrafish embryo xenotransplantation conditions by increasing incubation temperature and establishing a proliferation index with ZFtool. BMC Cancer, 18.","DOI":"10.1186\/s12885-017-3919-8"},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Cornet, C., Dyballa, S., Terriente, J., and Di Giacomo, V. (2019). ZeOncoTest: Refining and Automating the Zebrafish Xenograft Model for Drug Discovery in Cancer. Pharmaceuticals, 13.","DOI":"10.3390\/ph13010001"},{"key":"ref_123","unstructured":"ZeClinics (2020, May 07). Powering Discovery with Zebrafish. Available online: https:\/\/www.zeclinics.com\/."},{"key":"ref_124","first-page":"3129748","article-title":"Zebrafish Xenograft Model of Human Lung Cancer for Evaluating Osimertinib Resistance","volume":"2019","author":"Li","year":"2019","journal-title":"BioMed Res. Int."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ydbio.2019.04.005","article-title":"Automated in vivo screen in zebrafish identifies Clotrimazole as targeting a metabolic vulnerability in a melanoma model","volume":"457","author":"Precazzini","year":"2020","journal-title":"Dev. Biol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"4905","DOI":"10.2147\/CMAR.S196372","article-title":"Apatinib enhances chemosensitivity of gastric cancer to paclitaxel and 5-fluorouracil","volume":"11","author":"Xu","year":"2019","journal-title":"Cancer Manag. Res."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"102578","DOI":"10.1016\/j.ebiom.2019.11.039","article-title":"Developments in zebrafish avatars as radiotherapy sensitivity reporters\u2014Towards personalized medicine","volume":"51","author":"Costa","year":"2020","journal-title":"EBioMedicine"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"31958","DOI":"10.18632\/oncotarget.24110","article-title":"Ponatinib exerts anti-angiogenic effects in the zebrafish and human umbilical vein endothelial cells via blocking VEGFR signaling pathway","volume":"9","author":"Ai","year":"2018","journal-title":"Oncotarget"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"111609","DOI":"10.1016\/j.ejmech.2019.111609","article-title":"Pyrazolo-benzothiazole hybrids: Synthesis, anticancer properties and evaluation of antiangiogenic activity using in vitro VEGFR-2 kinase and in vivo transgenic zebrafish model","volume":"182","author":"Reddy","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3389\/fphar.2019.00349","article-title":"Phthalimide Derivative Shows Anti-angiogenic Activity in a 3D Microfluidic Model and No Teratogenicity in Zebrafish Embryos","volume":"10","author":"Mercurio","year":"2019","journal-title":"Front. Pharmacol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"33237","DOI":"10.18632\/oncotarget.8909","article-title":"In vivo screening and discovery of novel candidate thalidomide analogs in the zebrafish embryo and chicken embryo model systems","volume":"7","author":"Beedie","year":"2016","journal-title":"Oncotarget"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"108607","DOI":"10.1016\/j.biopha.2019.108607","article-title":"Network-pharmacology-based identification of caveolin-1 as a key target of Oldenlandia diffusa to suppress breast cancer metastasis","volume":"112","author":"Yang","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"125727","DOI":"10.1016\/j.chemosphere.2019.125727","article-title":"Isoliquiritigenin triggers developmental toxicity and oxidative stress\u2013mediated apoptosis in zebrafish embryos\/larvae via Nrf2-HO1\/JNK-ERK\/mitochondrion pathway","volume":"246","author":"Song","year":"2020","journal-title":"Chemosphere"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"16431","DOI":"10.1002\/jcp.28312","article-title":"Design and synthesis of novel celastrol derivative and its antitumor activity in hepatoma cells and antiangiogenic activity in zebrafish","volume":"234","author":"Wang","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"8347","DOI":"10.18632\/aging.102323","article-title":"Gomisin M2 from Baizuan suppresses breast cancer stem cell proliferation in a zebrafish xenograft model","volume":"11","author":"Yang","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"152843","DOI":"10.1016\/j.phymed.2019.152843","article-title":"Aloperine induces apoptosis and G2\/M cell cycle arrest in hepatocellular carcinoma cells through the PI3K\/Akt signaling pathway","volume":"61","author":"Liu","year":"2019","journal-title":"Phytomedicine"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"10488","DOI":"10.1021\/acs.jmedchem.8b01018","article-title":"Tanshinone-IIA-Based Analogues of Imidazole Alkaloid Act as Potent Inhibitors to Block Breast Cancer Invasion and Metastasis in Vivo","volume":"61","author":"Wu","year":"2018","journal-title":"J. Med. Chem."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.ejmech.2019.06.015","article-title":"Enrichment of novel quinazoline derivatives with high antitumor activity in mitochondria tracked by its self-fluorescence","volume":"178","author":"Zhang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Lin, H.-S., Huang, Y.-L., Wang, Y.-R.S., Hsiao, E., Hsu, T.-A., Shiao, H.-Y., Jiaang, W.-T., Sampurna, B.P., Lin, K.-H., and Wu, M.-S. (2019). Identification of Novel Anti-Liver Cancer Small Molecules with Better Therapeutic Index Than Sorafenib via Zebrafish Drug Screening Platform. Cancers, 11.","DOI":"10.3390\/cancers11060739"},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Costa, M., Rosa, F., Ribeiro, T., Hernandez-Bautista, R., Bonaldo, M., Silva, N.G., Eir\u00edksson, F., Thorsteinsd\u00f3ttir, M., Ussar, S., and Urbatzka, R. (2019). Identification of cyanobacterial strains with potential for the treatment of obesity-related co-morbidities by bioactivity, toxicity evaluation and metabolite profiling. Mar. Drugs, 17.","DOI":"10.3390\/md17050280"},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Carrillo, P., Mart\u00ednez-Poveda, B., Cheng-S\u00e1nchez, I., Guerra, J., Tobia, C., L\u00f3pez-Romero, J.M., Sarabia, F., Medina, M.\u00c1., and Quesada, A.R. (2019). Exploring the Antiangiogenic Potential of Solomonamide A Bioactive Precursors: In Vitro and in Vivo Evidences of the Inhibitory Activity of Solo F-OH During Angiogenesis. Mar. Drugs, 17.","DOI":"10.3390\/md17040228"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.2147\/DDDT.S145956","article-title":"Murrangatin suppresses angiogenesis induced by tumor cell\u2013derived media and inhibits AKT activation in zebrafish and endothelial cells","volume":"12","author":"Long","year":"2018","journal-title":"Drug Des. Devel. Ther."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.envpol.2019.07.081","article-title":"Mitochondrial dysfunction, apoptosis and transcriptomic alterations induced by four strobilurins in zebrafish (Danio rerio) early life stages","volume":"253","author":"Jiang","year":"2019","journal-title":"Environ. Pollut."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1021\/acschembio.5b00860","article-title":"Multidimensional Screening Platform for Simultaneously Targeting Oncogenic KRAS and Hypoxia-Inducible Factors Pathways in Colorectal Cancer","volume":"11","author":"Bousquet","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s10126-019-09889-8","article-title":"Rapid Analysis of Effects of Environmental Toxicants on Tumorigenesis and Inflammation Using a Transgenic Zebrafish Model for Liver Cancer","volume":"21","author":"Yang","year":"2019","journal-title":"Mar. Biotechnol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"761820","DOI":"10.1155\/2015\/761820","article-title":"Peptide-Based Treatment: A Promising Cancer Therapy","volume":"2015","author":"Xiao","year":"2015","journal-title":"J. Immunol. Res."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.canlet.2014.05.002","article-title":"Peptide-based cancer therapy: Opportunity and challenge","volume":"351","author":"Wu","year":"2014","journal-title":"Cancer Lett."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3389\/fmicb.2020.00405","article-title":"Exploiting Zebrafish Xenografts for Testing the in vivo Antitumorigenic Activity of Microcin E492 Against Human Colorectal Cancer Cells","volume":"11","author":"Varas","year":"2020","journal-title":"Front. Microbiol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"19156","DOI":"10.1038\/srep19156","article-title":"A novel cell-penetrating peptide suppresses breast tumorigenesis by inhibiting \u03b2-catenin\/LEF-1 signaling","volume":"6","author":"Hsieh","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"26072","DOI":"10.18632\/oncotarget.25437","article-title":"Induction of apoptosis and suppression of tumor growth by Nur77-derived Bcl-2 converting peptide in chemoresistant lung cancer cells","volume":"9","author":"Pearce","year":"2018","journal-title":"Oncotarget"},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Cordeiro, M., Carvalho, L., Silva, J., Sa\u00fade, L., Fernandes, A.R., and Baptista, P.V. (2017). Gold Nanobeacons for Tracking Gene Silencing in Zebrafish. Nanomaterials, 7.","DOI":"10.3390\/nano7010010"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s10616-014-9735-y","article-title":"The zebrafish\/tumor xenograft angiogenesis assay as a tool for screening anti-angiogenic miRNAs","volume":"67","author":"Chiavacci","year":"2014","journal-title":"Cytotechnology"},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Kiener, M., Chen, L., Krebs, M., Grosjean, J., Klima, I., Kalogirou, C., Riedmiller, H., Kneitz, B., Thalmann, G.N., and Snaar-Jagalska, E. (2019). MiR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivo. BMC Cancer, 19.","DOI":"10.1186\/s12885-019-5819-6"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"150927","DOI":"10.1016\/j.soncn.2019.08.006","article-title":"An Overview of Monoclonal Antibodies","volume":"35","author":"Bayer","year":"2019","journal-title":"Semin. Oncol. Nurs."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"E8234","DOI":"10.1073\/pnas.1618389114","article-title":"Single-cell functional and chemosensitive profiling of combinatorial colorectal therapy in zebrafish xenografts","volume":"114","author":"Fior","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"117402","DOI":"10.1016\/j.lfs.2020.117402","article-title":"A systematical comparison of anti-angiogenesis and anti-cancer efficacy of ramucirumab, apatinib, regorafenib and cabozantinib in zebrafish model","volume":"247","author":"Wu","year":"2020","journal-title":"Life Sci."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"15837","DOI":"10.1038\/s41598-018-34030-5","article-title":"Comparison of efficacy and toxicity of bevacizumab, endostar and apatinib in transgenic and human lung cancer xenograftzebrafish model","volume":"8","author":"Jin","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.2147\/DDDT.S166330","article-title":"Monitoring antiangiogenesis of bevacizumab in zebrafish","volume":"12","author":"Zhang","year":"2018","journal-title":"Drug Des. Devel. Ther."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"1700097","DOI":"10.1002\/biot.201700097","article-title":"Cancer Immunotherapy Using CAR-T Cells: From the Research Bench to the Assembly Line","volume":"13","author":"Ramos","year":"2018","journal-title":"Biotechnol. J."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13045-017-0423-1","article-title":"New development in CAR-T cell therapy","volume":"10","author":"Wang","year":"2017","journal-title":"J. Hematol. Oncol."},{"key":"ref_161","doi-asserted-by":"crossref","unstructured":"Pascoal, S., Salzer, B., Scheuringer, E., Wenninger-Weinzierl, A., Sturtzel, C., Holter, W., Taschner-Mandl, S., Lehner, M., and Distel, M. (2020). A preclinical embryonic zebrafish xenograft model to investigate CAR T cells in vivo. Cancers, 12.","DOI":"10.3390\/cancers12030567"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.msec.2016.12.110","article-title":"Anticancer activity of biologically synthesized silver and gold nanoparticles on mouse myoblast cancer cells and their toxicity against embryonic zebrafish","volume":"73","author":"Ramachandran","year":"2017","journal-title":"Mater. Sci. Eng. C"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.taap.2018.07.019","article-title":"Zebrafish (Danio rerio) model as an early stage screening tool to study the biodistribution and toxicity profile of doxorubicin-loaded mixed micelles","volume":"357","author":"Calienni","year":"2018","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"110386","DOI":"10.1016\/j.msec.2019.110386","article-title":"Cancer-targeted and intracellular delivery of Bcl-2-converting peptide with functional macroporous silica nanoparticles for biosafe treatment","volume":"108","author":"Wu","year":"2020","journal-title":"Mater. Sci. Eng. C"},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Haque, E., and Ward, A.C. (2018). Zebrafish as a model to evaluate nanoparticle toxicity. Nanomaterials, 8.","DOI":"10.3390\/nano8070561"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12951-016-0217-6","article-title":"Zebrafish: A complete animal model to enumerate the nanoparticle toxicity","volume":"14","author":"Chakraborty","year":"2016","journal-title":"J. Nanobiotechnol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jconrel.2019.08.022","article-title":"Nanomaterials meet zebrafish: Toxicity evaluation and drug delivery applications","volume":"311\u2013312","author":"Jia","year":"2019","journal-title":"J. Control. Release"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jconrel.2016.07.025","article-title":"Predicting the in vivo accumulation of nanoparticles in tumor based on in vitro macrophage uptake and circulation in zebrafish","volume":"244","author":"Chang","year":"2016","journal-title":"J. Control. Release"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"121296","DOI":"10.1016\/j.ijpharm.2021.121296","article-title":"Repurposing chlorpromazine for anti-leukaemic therapy by nanoparticle encapsulation","volume":"612","author":"Gundersen","year":"2022","journal-title":"Int. J. Pharm."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.biomaterials.2012.10.068","article-title":"Improving antiangiogenesis and anti-tumor activity of curcumin by biodegradable polymeric micelles","volume":"34","author":"Gong","year":"2013","journal-title":"Biomaterials"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.biomaterials.2018.03.037","article-title":"Dynamics of dual-fluorescent polymersomes with durable integrity in living cancer cells and zebrafish embryos","volume":"168","author":"Askes","year":"2018","journal-title":"Biomaterials"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3109\/17435390.2014.911381","article-title":"Preparation and properties of biocompatible PS-PEG\/calcium phosphate nanospheres","volume":"9","author":"Wang","year":"2015","journal-title":"Nanotoxicology"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1039\/C5NR07289A","article-title":"Zebrafish as a model system for characterization of nanoparticles against cancer","volume":"8","author":"Evensen","year":"2016","journal-title":"Nanoscale"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jconrel.2019.07.011","article-title":"The size and composition of polymeric nanocapsules dictate their interaction with macrophages and biodistribution in zebrafish","volume":"308","author":"Peleteiro","year":"2019","journal-title":"J. Control. Release"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.1039\/C8SC04884C","article-title":"Efficient cell surface labelling of live zebrafish embryos: Wash-free fluorescence imaging for cellular dynamics tracking and nanotoxicity evaluation","volume":"10","author":"Jia","year":"2019","journal-title":"Chem. Sci."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.drudis.2012.08.002","article-title":"Emergence of zebrafish models in oncology for validating novel anticancer drug targets and nanomaterials","volume":"18","author":"Mimeault","year":"2013","journal-title":"Drug Discov. Today"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1038\/aps.2018.9","article-title":"Delivery of mitochondriotropic doxorubicin derivatives using self-assembling hyaluronic acid nanocarriers in doxorubicin-resistant breast cancer","volume":"39","author":"Liu","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.biomaterials.2015.02.108","article-title":"Improving the anti-ovarian cancer activity of docetaxel with biodegradable self-assembly micelles through various evaluations","volume":"53","author":"Gao","year":"2015","journal-title":"Biomaterials"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.actbio.2018.03.013","article-title":"Targeting tumor hypoxia with stimulus-responsive nanocarriers in overcoming drug resistance and monitoring anticancer efficacy","volume":"71","author":"Xie","year":"2018","journal-title":"Acta Biomater."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"9873","DOI":"10.1038\/s41598-021-87968-4","article-title":"Edelfosine nanoemulsions inhibit tumor growth of triple negative breast cancer in zebrafish xenograft model","volume":"11","author":"Saraiva","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_181","doi-asserted-by":"crossref","unstructured":"Moret, F., Conte, C., Esposito, D., Dal Poggetto, G., Avitabile, C., Ungaro, F., Tiso, N., Romanelli, A., Laurienzo, P., and Reddi, E. (2022). Biodegradable nanoparticles combining cancer cell targeting and anti-angiogenic activity for synergistic chemotherapy in epithelial cancer. Drug Deliv. Transl. Res., 1\u201313.","DOI":"10.21203\/rs.3.rs-879223\/v1"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"5270","DOI":"10.1039\/C4NR07641A","article-title":"Biodegradable polymeric micelle-encapsulated doxorubicin suppresses tumor metastasis by killing circulating tumor cells","volume":"7","author":"Deng","year":"2015","journal-title":"Nanoscale"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jconrel.2018.02.026","article-title":"Co-delivery nanoparticle to overcome metastasis promoted by insufficient chemotherapy","volume":"275","author":"Zhou","year":"2018","journal-title":"J. Control. Release"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s13046-017-0631-0","article-title":"Patient-derived xenograft in zebrafish embryos: A new platform for translational research in gastric cancer","volume":"36","author":"Wu","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.3748\/wjg.v26.i21.2792","article-title":"Use of zebrafish embryos as avatar of patients with pancreatic cancer: A new xenotransplantation model towards personalized medicine","volume":"26","author":"Usai","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"ref_186","doi-asserted-by":"crossref","unstructured":"Costa, B., Estrada, M.F., Mendes, R.V., and Fior, R. (2020). Zebrafish Avatars towards Personalized Medicine\u2014A Comparative Review between Avatar Models. Cells, 9.","DOI":"10.3390\/cells9020293"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s42003-020-1015-0","article-title":"Zebrafish xenografts as a fast screening platform for bevacizumab cancer therapy","volume":"3","author":"Mendes","year":"2020","journal-title":"Commun. Biol."},{"key":"ref_188","doi-asserted-by":"crossref","unstructured":"Gauert, A., Olk, N., Pimentel-Guti\u00e9rrez, H., Astrahantseff, K., Jensen, L.D., Cao, Y., Eggert, A., Eckert, C., and Hagemann, A.I.H. (2020). Fast, in vivo model for drug-response prediction in patients with b-cell precursor acute lymphoblastic leukemia. Cancers, 12.","DOI":"10.3390\/cancers12071883"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1182\/blood-2016-03-704460","article-title":"A clinically relevant in vivo zebrafish model of human multiple myeloma to study preclinical therapeutic efficacy","volume":"128","author":"Lin","year":"2016","journal-title":"Blood"},{"key":"ref_190","doi-asserted-by":"crossref","unstructured":"Usai, A., Di Franco, G., Piccardi, M., Cateni, P., Pollina, L.E., Vivaldi, C., Vasile, E., Funel, N., Palmeri, M., and Dente, L. (2021). Zebrafish patient-derived xenografts identify chemo-response in pancreatic ductal adenocarcinoma patients. Cancers, 13.","DOI":"10.3390\/cancers13164131"},{"key":"ref_191","unstructured":"(2021, March 30). ClinicalTrials.gov, Available online: https:\/\/clinicaltrials.gov\/."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41568-020-0252-3","article-title":"Zebrafish patient avatars in cancer biology and precision cancer therapy","volume":"20","author":"Fazio","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/d41573-019-00165-x","article-title":"Zebrafish earn their drug discovery stripes","volume":"18","author":"Cully","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/nature05883","article-title":"Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis","volume":"447","author":"North","year":"2007","journal-title":"Nature"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nature09882","article-title":"DHODH modulates transcriptional elongation in the neural crest and melanoma","volume":"471","author":"White","year":"2011","journal-title":"Nature"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1084\/jem.20180939","article-title":"Zebrafish blastomere screen identifies retinoic acid suppression of MYB in adenoid cystic carcinoma","volume":"215","author":"Mandelbaum","year":"2018","journal-title":"J. Exp. Med."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"105366","DOI":"10.1016\/j.oraloncology.2021.105366","article-title":"A phase II trial of all-trans retinoic acid (ATRA) in advanced adenoid cystic carcinoma","volume":"119","author":"Hanna","year":"2021","journal-title":"Oral Oncol."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.eururo.2010.05.024","article-title":"Rosuvastatin, identified from a zebrafish chemical genetic screen for antiangiogenic compounds, suppresses the growth of prostate cancer","volume":"58","author":"Wang","year":"2010","journal-title":"Eur. Urol."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1172\/JCI65093","article-title":"Phenothiazines induce PP2A-mediated apoptosis in T cell acute lymphoblastic leukemia","volume":"124","author":"Gutierrez","year":"2014","journal-title":"J. Clin. Investig."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"127239","DOI":"10.1016\/j.bmcl.2020.127239","article-title":"Repurposing of antipsychotics perphenazine for the treatment of endometrial cancer","volume":"30","author":"Chen","year":"2020","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_201","doi-asserted-by":"crossref","unstructured":"Evason, K.J., Francisco, M.T., Juric, V., Balakrishnan, S., Lopez Pazmino, M.d.P., Gordan, J.D., Kakar, S., Spitsbergen, J., Goga, A., and Stainier, D.Y.R. (2015). Identification of Chemical Inhibitors of \u03b2-Catenin-Driven Liver Tumorigenesis in Zebrafish. PLoS Genet., 11.","DOI":"10.1371\/journal.pgen.1005305"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"40348","DOI":"10.18632\/oncotarget.9613","article-title":"Reprofiling using a zebrafish melanoma model reveals drugs cooperating with targeted therapeutics","volume":"7","author":"Jones","year":"2016","journal-title":"Oncotarget"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.trecan.2020.03.012","article-title":"Zebrafish Xenografts for Drug Discovery and Personalized Medicine","volume":"6","author":"Xiao","year":"2020","journal-title":"Trends Cancer"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/14\/9\/2238\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:04:43Z","timestamp":1760137483000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/14\/9\/2238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,30]]},"references-count":203,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,5]]}},"alternative-id":["cancers14092238"],"URL":"https:\/\/doi.org\/10.3390\/cancers14092238","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,30]]}}}